Shritirupati Balaji Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.30 M
as on 25-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 55.45%
(FY 2023)
- Profit -197.40%
(FY 2023)
- Ebitda 71.23%
(FY 2023)
- Net Worth -3998.28%
(FY 2023)
- Total Assets -50.86%
(FY 2023)
About Shritirupati Balaji Meditech
The Corporate was formerly known as Shritirupati Balaji Realtech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Hardik Sorayan, Usha, and Suresh Sheorain serve as directors at the Company.
- CIN/LLPIN
U85100DL2012PTC241143
- Company No.
241143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shritirupati Balaji Meditech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardik Sorayan  | Director | 19-Oct-2023 | Current |
| Usha | Director | 19-Oct-2023 | Current |
| Suresh Sheorain | Director | 19-Oct-2023 | Current |
Financial Performance of Shritirupati Balaji Meditech.
Shritirupati Balaji Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.45% increase. The company also saw a substantial fall in profitability, with a 197.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3998.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shritirupati Balaji Meditech?
Unlock access to Shritirupati Balaji Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shritirupati Balaji Meditech?
Unlock and access historical data on people associated with Shritirupati Balaji Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shritirupati Balaji Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shritirupati Balaji Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
